Inventor · disambiguated record
Ghiabe H. Guibinga
Also filed as: GUIBINGA GHIABE · GUIBINGA GHIABE H
6 granted patents·6 pending applications·21 citations·filing 2017–2025
78Inventor score
Top patents by PatentIndex Score
12 records- 0193US11325948B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPLEXUMA BIOTECH CORP·Filed 2020·Granted May 10, 2022·6 cites·27 claims
- 0292US12258574B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Granted Mar 25, 2025·1 cites·26 claims
- 0392US10596274B2Methods and compositions for transducing lymphocytes and regulated expansion thereofEXUMA BIOTECH CORP·Filed 2017·Granted Mar 24, 2020·10 cites·24 claims
- 0488US11111505B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2017·Granted Sep 7, 2021·3 cites·21 claims
- 0587US12325728B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79BEXUMA BIOTECH CORP·Filed 2022·Granted Jun 10, 2025·1 cites·26 claims
- 0680US2023257776A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Application pending·0 cites
- 0777US2025236889A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2025·Application pending·0 cites
- 0874US2025011401A1Optimized nucleic acid antibody constructsWISTAR INST·Filed 2024·Application pending·0 cites
- 0973US2021403952A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 1062US2023392139A1Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Application pending·0 cites
- 1160US12054537B2Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodiesWISTAR INST·Filed 2018·Granted Aug 6, 2024·0 cites·5 claims
- 1245US2020397821A1Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →